Health technology assessment (HTA) is how health systems decide whether a medicine offers enough value to fund. It weighs clinical benefit, cost and impact on patients. For pharma teams, it shapes who gets access and when.
What is HTA, in plain English
HTA is a structured, evidence-based review of a health technology, such as a medicine, a device or a procedure. It helps decision-makers choose what to fund, at what price and for which patients. In simple terms, it asks four questions: does it work, for whom, at what cost, and compared with what we already do?
How HTA decisions are made
Each system has its own process, but most look at the same four areas: